Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Vox Sang ; 119(6): 556-562, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38523360

RESUMEN

BACKGROUND AND OBJECTIVES: Malaria continues to be a significant public health concern in India, with several regions experiencing endemicity and sporadic outbreaks. The prevalence of malaria in blood donors, in India, varies between 0.02% and 0.07%. Common techniques to screen for malaria, in blood donors and patients, include microscopic smear examination and rapid diagnostic tests (RDTs) based on antigen detection. The aim of this study was to evaluate a new fully automated analyser, XN-31, for malaria detection, as compared with current practice of using RDT. MATERIALS AND METHODS: Cross-sectional analytical study was conducted to evaluate clinical sensitivity and specificity of new automated analyser XN-31 among blood donors' samples and clinical samples (patients with suspicion of malaria) from outpatient clinic collected over between July 2021 and October 2022. No additional sample was drawn from blood donor or patient. All blood donors and patients' samples were processed by malaria rapid diagnostic test, thick-smear microscopy (MIC) and the haematology analyser XN-31. Any donor blood unit incriminated for malaria was discarded. Laboratory diagnosis using MIC was considered the 'gold standard' in the present study. Clinical sensitivity and specificity of XN-31 were compared with the gold standard. RESULTS: Fife thousand and five donor samples and 82 diagnostic samples were evaluated. While the clinical sensitivity and specificity for donor samples were 100%, they were 72.7% and 100% for diagnostic samples. CONCLUSION: Automated haematology analysers represent a promising solution, as they can deliver speedy and sensitive donor malaria screening assessments. This method also has the potential to be used for pre-transfusion malaria screening along with haemoglobin estimation.


Asunto(s)
Donantes de Sangre , Malaria , Humanos , India , Malaria/diagnóstico , Malaria/sangre , Estudios Transversales , Femenino , Masculino , Sensibilidad y Especificidad , Adulto , Pruebas Hematológicas/métodos , Pruebas Hematológicas/instrumentación
4.
Pediatr Transplant ; 19(7): E177-80, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26184957

RESUMEN

EBV-associated PTLD is increasingly recognized as an important cause of morbidity and mortality in both solid organ and hematopoietic stem cell transplant recipients. Mortality rates due to PTLD and virus-induced HLH are reported to be quite high. We report a case of EBV-associated PTLD and HLH in a child after liver transplantation who was successfully managed due to timely intervention. This case highlights that measurement of EBV load by quantitative polymerase chain reaction assays is an important aid in the surveillance and diagnosis of PTLD and early detection of EBV-induced PTLD, and aggressive treatment with rituximab is a key to survival in patients who have undergone liver transplantation.


Asunto(s)
Citofagocitosis , Infecciones por Virus de Epstein-Barr/complicaciones , Trasplante de Hígado , Trastornos Linfoproliferativos/virología , Complicaciones Posoperatorias/virología , Preescolar , Infecciones por Virus de Epstein-Barr/tratamiento farmacológico , Infecciones por Virus de Epstein-Barr/fisiopatología , Femenino , Humanos , Factores Inmunológicos/uso terapéutico , Trastornos Linfoproliferativos/diagnóstico , Trastornos Linfoproliferativos/tratamiento farmacológico , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/tratamiento farmacológico , Rituximab/uso terapéutico
6.
Inflammopharmacology ; 21(5): 377-83, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22956243

RESUMEN

The present study has evaluated the healing effects of extract of dried fruit pulp of Terminalia chebula (TCE) on acetic acid (AA)-induced colitis in rats. TCE (600 mg/kg) showed healing effects against AA-induced colonic damage score and weight when administered orally daily for 14 days. TCE was further studied for its effects on various physical (mucus/blood in stool and stool frequency, food and water intake and body weight changes), histology, antibacterial activity and free radicals (NO and LPO), antioxidants (SOD, CAT and GSH) and myeloperoxidase in colonic tissue. Intra-colonic AA administration increased colonic mucosal damage and inflammation, mucus/bloody diarrhoea, stool frequency, but decreased body weight which were reversed by TCE and sulfasalazine (SS, positive control) treatments. TCE showed antibacterial activity and both TCE and SS enhanced the antioxidants, but decreased free radicals and myeloperoxidase activities affected in acetic acid-induced colitis. TCE indicated the presence of active principles with proven antioxidants, anti-inflammatory, immunomodulatory, and free radical scavenging and healing properties. Thus, TCE seemed to be safe and effective in healing experimental colitis.


Asunto(s)
Antiulcerosos/uso terapéutico , Antioxidantes/metabolismo , Colitis Ulcerosa/tratamiento farmacológico , Radicales Libres/metabolismo , Extractos Vegetales/uso terapéutico , Terminalia/química , Ácido Acético/farmacología , Animales , Antiulcerosos/administración & dosificación , Biomarcadores/metabolismo , Colitis Ulcerosa/inducido químicamente , Colitis Ulcerosa/inmunología , Colitis Ulcerosa/patología , Modelos Animales de Enfermedad , Femenino , Frutas/química , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Masculino , Ratones , Extractos Vegetales/administración & dosificación , Ratas , Ratas Endogámicas
7.
Cureus ; 15(10): e46855, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37954811

RESUMEN

Background Nursing professionals, comprising the largest workforce engaged in the primary healthcare system, play a pivotal role in addressing population health needs. However, gaps in the training of nurses and midwives in lower-middle-income countries may undermine their performance and necessary skill development for fulfilling key population health needs. Substantial challenges exist in improving the regular curricular and refresher training of diplomate nurses and midwives working in primary care facilities and supporting both clinical care and health promotion functions. The study objective was to conduct a gap analysis in the present nursing curriculum and training profile of general duty midwives working in urban primary health facilities and understand their expectations and preferences from the planned refresher training course.  Methods We conducted a qualitative explorative study among General Nursing midwives (GNMs) working in urban primary health facilities in the Gurugram district of Haryana, India to conduct a gap analysis in their present curriculum and training preferences.  Results A total of 17 nurses with a mean (SD) age of 33.52 (4.75) years and an average nursing work experience of 5.35 (0.56) years were interviewed in-depth. Lack of practical applicability, complex study material, inexperienced tutors, and weak English language comprehension were key barriers in the existing nursing curriculum. The nurses expressed willingness to participate in refresher training with varied expectations, although there existed a distinct preference for short, flexible, and blended online-offline modes of training.  Conclusions Strengthening GNM nursing education should be prioritized in Indian health settings with the focus on improving student comprehension through vernacular instruction when feasible, and capacity building of tutors, with avenues for continued training and education. There is also a need for strengthening the curriculum related to key emergent public health challenges related to non-communicable diseases and mental health, as also skills for client and patient counseling and communication.

8.
Int J Lab Hematol ; 45(3): 282-288, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36782379

RESUMEN

INTRODUCTION: COVID-19 usually presents with upper respiratory tract infection in varying severity which can lead to sepsis. Early prediction of sepsis may reduce mortality by timely interventions. The intended purpose of this study was to determine whether the advanced parameters like the extended inflammation parameters (EIPs) can predict prognosis and early progression to sepsis as a sequel of COVID-19 infection and can be used as a screening profile. Also, to evaluate the Intensive Care Infection Score (ICIS) and the COVID-19 prognostic score and validate the scores for our population. METHODS: Prospective observational study of 50 reverse transcription- polymerase chain reaction (RT-PCR) proven admitted COVID-19 patients. The data assessed included complete blood counts (CBC) with EIP measurements, from Day 1 of admission to Day 10. The following groups were studied: noncritical (NC) and critical illness (CI) in COVID-19 positive cases, COVID negative sepsis and nonsepsis cases, and healthy volunteers for reference range. RESULTS: The parameters that showed statistically significant higher mean in CI group compared to the NC group are reactive lymphocyte number and percentage (RE-LYMPH#, RE-LYMPH%), antibody synthesizing lymphocyte number and percentage (AS-LYMPH#, AS-LYMPH%), Reactive monocyte count and percentage (RE-MONO#, RE-MONO%/M), ICIS, COVID-19 prognostic score (p-value <0.05). The AUC confirmed the diagnostic accuracy of all these parameters. From the multivariate logistic regression, the significant risk factor was RE-LYMPH# with cut-off >0.10 (p value: 0.011). CONCLUSION: The new EIP parameters, RE-MONO#, RE-MONO%/M, ICIS score and COVID-19 prognostic score are useful for early prediction of critical illness. AS-LYMPH is the most useful predictor of critical illness on multivariate analysis. RE-MONO# and RE-MONO%/M parameter are useful in distinguishing critical and noncritical non-COVID and COVID-19 patients.


Asunto(s)
COVID-19 , Sepsis , Humanos , COVID-19/diagnóstico , Curva ROC , Enfermedad Crítica , Pronóstico , Estudios Retrospectivos
9.
Indian J Hematol Blood Transfus ; 39(1): 141-145, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36699427

RESUMEN

Purpose of current study was to categorize WHO defined B-Acute Lymphoblastic Leukemia (B-ALL) cases into 3 cytogenetic risk groups (good, intermediate and poor) and to see their correlation with age, NCI risk criteria and treatment response. Clinical and diagnostic details were collected for 78 newly diagnosed B-ALL patients which included bone marrow morphology, flow cytometry immunophenotyping, karyotyping, FISH and RT-PCR. Study cohort comprised 44/78 (56.4%) children including 3 infants and 34/78 (43.6%) adults. Median age for paediatric group was 6 years (3 months-17 years) and for adults was 40.5 years (18 to 75 years). According to NCI risk criteria, excluding infants, 54 (72%) were high risk and 21 (28%) were standard risk. Clonal cytogenetic abnormality was detected in 59/78 cases (75.6%), while 19/78 (24.4%) cases showed normal karyotype. There was significant association of cytogenetic risk groups to age distribution (p value < 0.001) and NCI risk groups (p value < 0.001). There was no significant correlation of CNS involvement with cytogenetic risk groups (p = 0.064). Association of Day 8 steroid response and Day 15 bone marrow status with cytogenetic risk groups was significant (p = 0.006 and p = 0.003 respectively). Post treatment bone marrow status on Day 33 and Day 79 was available for 52 and 42 cases respectively. 9 adults died during induction phase. Day 33 post induction morphological remission was achieved in 51/52 cases (98%) and 1/52 (2.0%) were not in remission. Day 79 post induction morphological remission was achieved in 41/42 cases (98%) and 1/42 (2.0%) were not in remission. Day 33 or End of induction flow MRD (measurable residual disease) was negative in 39/52 (75.0%) patients and positive in 13/52 (25.0%) patients. Day 79 flow MRD was negative in 37/42 (88.1%) and positive in 5/42 (11.9%). Cytogenetic risk groups showed statistically significant Day 33 and Day 79 treatment response (morphologic remission: p = 0.009 and 0.003, flow MRD: p = 0.004 and p = 0.012 respectively). We concluded that cytogenetic risk groups showed statistically significant association with age, NCI risk criteria and treatment response.

11.
12.
Cogn Neurodyn ; 16(5): 1045-1057, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36237400

RESUMEN

In recent days, Cognitive Cyber-Physical System (CCPS) has gained significant interest among interdisciplinary researchers which integrates machine learning (ML) and artificial intelligence (AI) techniques. This era is witnessing a rapid transformation in digital technology and AI where brain-inspired computing-based solutions will play a vital role in industrial informatics. The application of CCPS with brain-inspired computing in Industry 4.0 will create a significant impact on industrial evolution. Though the CCPSs in industrial environment offer several merits, security remains a challenging design issue. The rise of artificial intelligence AI techniques helps to address cybersecurity issues related to CCPS in industry 4.0 environment. With this motivation, this paper presents a new AI-enabled multimodal fusion-based intrusion detection system (AIMMF-IDS) for CCPS in industry 4.0 environment. The proposed model initially performs the data pre-processing technique in two ways namely data conversion and data normalization. In addition, improved fish swarm optimization based feature selection (IFSO-FS) technique is used for the appropriate selection of features. The IFSO technique is derived by the use of Levy Flight (LF) concept into the searching mechanism of the conventional FSO algorithm to avoid the local optima problem. Since the single modality is not adequate to accomplish enhanced detection performance, in this paper, a weighted voting based ensemble model is employed for the multimodal fusion process using recurrent neural network (RNN), bi-directional long short term memory (Bi-LSTM), and deep belief network (DBN), depicts the novelty of the work. The simulation analysis of the presented model highlighted the improved performance over the recent state of art techniques interms of different measures.

14.
Turk Patoloji Derg ; 36(2): 173-177, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-30632123

RESUMEN

Inflammatory myofibroblastic tumor (IMT) of lung is a rare tumor, accounting for ~0.7% of all lung tumors with varied clinical and radiological presentations. The origin of this tumor is unknown but some studies suggest that it might be a true neoplasm as some mutations on chromosome 2p23 of anaplastic lymphoma kinase (ALK) have been found to be related to this tumor. The morphology of IMT is quite vague and the histopathological diagnosis is predominantly given on excision specimens; in fact, only 6.3% of cases are diagnosed based on analysis of biopsy specimens alone. We illustrate a case of IMT diagnosed in a young male on core biopsy, where the case presented with a large tumor in the lung with metastases to multiple sites that was hence unresectable. Post 3 months of treatment with Crizotinib, there was significant reduction in the tumor size. Another interesting finding was that the ALK immunostain, which helped immensely in the diagnosis, was appreciated better on the Ventana platform rather than on the Dako platform.


Asunto(s)
Quinasa de Linfoma Anaplásico/análisis , Neoplasias Pulmonares/diagnóstico , Miofibroma/diagnóstico , Adulto , Antineoplásicos/uso terapéutico , Biomarcadores de Tumor/análisis , Biopsia con Aguja Gruesa , Crizotinib/uso terapéutico , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/patología , Masculino , Miofibroma/tratamiento farmacológico , Miofibroma/patología
15.
Indian J Exp Biol ; 47(8): 649-59, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19775071

RESUMEN

Pongamia pinnata has been advocated in Ayurveda for the treatment of various inflammatory conditions and dyspepsia. The present work includes initial phytochemical screening and study of ulcer protective and healing effects of methanolic extract of seeds of P. pinnata (PPSM) in rats. Phytochemical tests indicated the presence of flavonoids in PPSM. PPSM when administered orally (po) showed dose-dependent (12.5-50 mg/kg for 5 days) ulcer protective effects against gastric ulcer induced by 2 h cold restraint stress. Optimal effective dose of PPSM (25 mg/kg) showed antiulcerogenic activity against acute gastric ulcers (GU) induced by pylorus ligation and aspirin and duodenal ulcer induced by cysteamine but not against ethanol-induced GU. It healed chronic gastric ulcer induced by acetic acid when given for 5 and 10 days. Further, its effects were studied on various parameters of gastric offensive acid-pepsin secretion, lipid peroxidation (LPO) and nitric oxide (NO) and defensive mucosal factors like mucin secretion and mucosal cell shedding, glycoproteins, proliferation and antioxidants; catalase (CAT), superoxide dismutase (SOD) and glutathione (GSH) levels. PPSM tended to decrease acid output and increased mucin secretion and mucosal glycoproteins, while it decreased gastric mucosal cell shedding without any effect on cell proliferation. PPSM significantly reversed the increase in gastric mucosal LPO, NO and SOD levels caused by CRS near to the normal level while it tended to increase CAT and GSH level decreased by CRS and ethanol respectively. Thus, the ulcer protective effects of PPSM may be attributed to the presence of flavonoids and the actions may be due to its effects both on mucosal offensive and defensive factors.


Asunto(s)
Úlcera Duodenal/prevención & control , Mucosa Gástrica/efectos de los fármacos , Millettia/química , Extractos Vegetales/farmacología , Semillas/química , Úlcera Gástrica/prevención & control , Ácido Acético/toxicidad , Animales , Aspirina/toxicidad , Catalasa/metabolismo , Cromatografía en Capa Delgada/métodos , Frío , Úlcera Duodenal/etiología , Femenino , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Glutatión/metabolismo , Ligadura/efectos adversos , Peroxidación de Lípido/efectos de los fármacos , Masculino , Metanol/química , Óxido Nítrico/metabolismo , Pepsina A/metabolismo , Fitoterapia , Extractos Vegetales/química , Píloro/cirugía , Ratas , Restricción Física/efectos adversos , Úlcera Gástrica/etiología , Superóxido Dismutasa/metabolismo
16.
Indian J Exp Biol ; 47(1): 32-40, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19317349

RESUMEN

Plantain banana (M. sapientum var. paradisiaca, MS) has been shown to possess ulcer healing activity. The present work with plantain banana was undertaken with the premise that the drug promoting ulcer healing could have effect on wound healing also. Wound healing activity of MS was studied in terms of (i) percent wound contraction, epithelization period and scar area; (ii) wound breaking strength and (iii) on granulation tissue antioxidant status [estimation of superoxide dismutase (SOD) and reduced glutathione (GSH), free radical (lipid peroxidation, an indicator of tissue damage) and connective tissue formation and maturation (hexuronic acid, hydroxyproline and hexosamine levels)] in excision, incision and dead space wound models respectively. The rats were given graded doses (50-200 mg/kg/day) of aqueous (MSW) and methanolic (MSE) extracts of MS orally for a period of 10-21 days depending upon the type of study. Both extracts (100 mg/kg) when studied for incision and dead space wounds parameters, increased wound breaking strength and levels of hydroxyproline, hexuronic acid, hexosamine, superoxide dismutase, reduced glutathione in the granulation tissue and decreased percentage of wound area, scar area and lipid peroxidation when compared with the control group. Both the extracts showed good safety profile. Plantain banana thus, favoured wound healing which could be due to its antioxidant effect and on various wound healing biochemical parameters.


Asunto(s)
Musa/química , Extractos Vegetales/farmacología , Cicatrización de Heridas/efectos de los fármacos , Animales , Antioxidantes/metabolismo , Relación Dosis-Respuesta a Droga , Fitoterapia , Extractos Vegetales/administración & dosificación , Ratas
17.
Trop Doct ; 39(4): 247-8, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19762585

RESUMEN

We present a case of disseminated histoplasmosis with acquired immunodeficiency syndrome (AIDS). A 38-year-old woman presented with fever, cough, dysphagia, significant weight loss and a loss of appetite. She also suffered from anaemia and cervical lymphadenopathy. A lymph node biopsy and a bone marrow aspirate showed intracellular yeast forms of Histoplasma capsulatum. She improved with parenteral amphotericin B and oral itraconazole. Even though histoplasmosis is not endemic in South East Asia and India, it should be kept in mind when evaluating AIDS patients in view of the current scenario of the pandemic.


Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/diagnóstico , Histoplasmosis/diagnóstico , Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Adulto , Antifúngicos/uso terapéutico , Femenino , Histoplasmosis/tratamiento farmacológico , Humanos , India
18.
Indian J Physiol Pharmacol ; 53(1): 16-24, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19810572

RESUMEN

Diabetes has been reported to cause an increase in offensive and decrease in defensive gastric mucosal factors, the imbalance of which can cause ulceration and delay the ulcer healing. Eugenia jambolana has been documented to have both antidiabetic and antiulcer activities. The present study evaluates the effects of ethanolic extract of E. jambolana on gastric ulcer healing and on rat gastric mucosal defensive factors in gastric ulcer with co-occurring diabetes. E. jambolana extract was administered orally in the dose of 200 mg/kg once daily for 10 days. E. jambolana extract increased mucin secretion, mucosal glycoprotein and glutathione levels and decreased the lipid peroxidation in gastric mucosa of diabetic rats. Its treatment also reversed the decrease in life span of gastric mucosal cells as indicated by decreased cell shedding in the gastric juice but found to have no effect on cell proliferation, indicating enhanced defensive status. E. jambolana extract was effective in reversing the delayed healing of gastric ulcer in diabetic rats near to the normal level. E. jambolana showed better ulcer healing effect than glibenclamide, because of its both antihyperglycemic and mucosal defensive actions. It could thus, be a better choice for treating gastric ulcers co-occurring with diabetes.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Mucosa Gástrica/efectos de los fármacos , Fitoterapia , Extractos Vegetales/uso terapéutico , Úlcera Gástrica/tratamiento farmacológico , Syzygium , Animales , Proliferación Celular/efectos de los fármacos , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/complicaciones , Femenino , Jugo Gástrico/efectos de los fármacos , Jugo Gástrico/metabolismo , Mucosa Gástrica/metabolismo , Glutatión , Glicoproteínas/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Mucinas/metabolismo , Ratas , Ratas Endogámicas , Semillas , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/complicaciones
19.
Indian J Physiol Pharmacol ; 53(2): 137-46, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-20112817

RESUMEN

Diabetes has been reported to increase propensity to peptic ulceration through its effect both on offensive and defensive mucosal factors. Seeds of Eugenia jambolana (EJ) have been reported to have both antidiabetic as well as ulcer protective effects. The present study evaluates the antidiabetic effects of ethanolic extract of dried seed kernel of Eugenia jambolana (EJE) and its comparative effect on gastric ulceration and acid-pepsin secretion with standard antisecretory FL-blocker. Ranitidine and antidiabetic glibenclamide with a premise that Eugenia jambolana may show better ulcer healing effects by promoting defensive or reducing offensive mucosal factors in mild diabetes (MD) rats. MD was produced in adult rats by administration of streptozotocin (45 mg/kg, ip). EJE was given orally in the doses of 100-400 mg/kg for 10 days and in the dose of 200 mg/kg for 30 days respectively to study its dose- and time-dependent effects on various diabetic parameters like blood glucose, serum cholesterol and triglycerides, insulin level and glycosylated hemoglobin. For ulcer protective and gastric secretion studies, EJE (200 mg/kg) was given orally for 10 days against 2 h cold restraint stress (CRS)-, 4 h pylorus ligation (PL), aspirin (ASP, 200 mg/kg, 4 h)--and 95% ethanol (EtOH, 1 ml/200 g, 1 h)-induced gastric ulcers and offensive acid-pepsin secretion after 4 h PL with co-occurring MD in rats. EJE showed dose-dependent decrease in blood glucose level in MD rats. Blood glucose level remained stable in mild diabetic rats from 3rd day onwards after streptozotocin administration (taken as 1st day for treatment) and EJE (200 mg/kg) showed anti-hyperglycemic effect on 10th day of its administration. Further, EJE in the above dose also decreased cholesterol level with little or no effect on triglycerides level and reversed the decrease and increase in insulin and glycosylated hemoglobin level near to the normal level as observed alter 30 days treatment in MD rats. MD rats exhibited an increased propensity to gastric ulceration induced by CRS, ASP, EtOH and PL and caused increase in acid-pepsin secretion. EJE was not only effective in reversing the increased propensity to ulceration in diabetic rats but also decreased the acid-pepsin output better than glibenclamide. The ulcer protective effect of Eugenia jambolana seems to be due to its antidiabetic and gastric antisecretory effects.


Asunto(s)
Antiulcerosos/farmacología , Diabetes Mellitus Experimental/tratamiento farmacológico , Ácido Gástrico/metabolismo , Mucosa Gástrica/efectos de los fármacos , Hipoglucemiantes/farmacología , Pepsina A/metabolismo , Extractos Vegetales/farmacología , Úlcera Gástrica/prevención & control , Syzygium , Animales , Antiulcerosos/aislamiento & purificación , Glucemia/efectos de los fármacos , Colesterol/sangre , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Experimental/metabolismo , Relación Dosis-Respuesta a Droga , Femenino , Mucosa Gástrica/metabolismo , Gliburida/farmacología , Hemoglobina Glucada/metabolismo , Hipoglucemiantes/aislamiento & purificación , Insulina/sangre , Masculino , Extractos Vegetales/aislamiento & purificación , Ranitidina/farmacología , Ratas , Semillas , Índice de Severidad de la Enfermedad , Úlcera Gástrica/etiología , Úlcera Gástrica/metabolismo , Syzygium/química , Factores de Tiempo , Triglicéridos/sangre
20.
Int J Surg Pathol ; 24(1): 70-2, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26338718

RESUMEN

Extrapulmonary tuberculosis coexistent with lymphomas in the same organ are rare and have been reported in the literature. The most common organs that are involved are small bowel, bronchus, kidney, and lymph nodes. Interestingly, the lymphoma that is commonly present with extrapulmonary tuberculosis is Hodgkin's lymphoma followed by low-grade non-Hodgkin's lymphoma. In the present study, we report a 60-year-old man with complaints of fever, loss of appetite, and generalized weakness. On investigation, generalized lymphadenopathy was noted, and the biopsy of cervical lymph node revealed coexistence of diffuse large B-cell lymphoma with extrapulmonary tuberculosis. This case is the second reported case of diffuse large B-cell lymphoma with extrapulmonary tuberculosis in the world and the first in India.


Asunto(s)
Ganglios Linfáticos/patología , Linfoma de Células B Grandes Difuso/patología , Tuberculosis/patología , Humanos , Linfoma de Células B Grandes Difuso/complicaciones , Masculino , Persona de Mediana Edad , Tuberculosis/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA